Table 3B.
Complication rates per patient for FIs of the orbital region (ORB).
| Implant material | TI | PEEK | PPE | ME | HA (/PLLA) | SI | PMMA | ePTFE | HTR | PRO | GC | PCL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total number of patients | 447 | 0 | 693 | 0 | 376 | 87 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total complication rate [%] | 46 (10) | 0 | 52 (7.5) | 0 | 26 (6.9) | 9 (10) | 0 | 0 | 0 | 0 | 0 | 0 |
| Infection/inflammation [%] | 10 (2.2) | 0 | 14 (2.0) | 0 | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 0 | 0 |
| Hematoma [%] | 0 | 0 | 0 | 0 | 3 (0.80) | 2 (2.3) | 0 | 0 | 0 | 0 | 0 | 0 |
| Persistent pain [%] | 8 (1.8) | 0 | 8 (1.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nerve injury [%] | 25 (5.6) | 0 | 27 (3.9) (2) | 0 | 23 (6.1) | 6 (6.9) | 0 | 0 | 0 | 0 | 0 | 0 |
| Wound dehiscence [%] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Implant exposure [%] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Displacement/extrusion [%] | 3 (0.67) | 0 | 3 (0.43) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bone resorption [%] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bone erosion [%] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TI, titanium; PEEK, polyetheretherketone; PPE, polyethylene; ePTFE, expanded polytetrafluorethylene; SI, silicone; ME, mersilene; HA/PLLA, hydroxylapatite/poly-l-lactide; PCL, polycaprolactone; PMMA, polymethylmethacrylate; GC, glass ceramics; PRO, Proplast; ZR, zirconium oxide; HTR, hard tissue replacement; FH, forehead; MF, midface; OF, orbitofrontal; FN, frontonasal; ORB, orbital; NOSE, nose; PN, paranasal; MAX, maxilla; MAN, mandible, MAL, malar; CHIN, chin.
Bold values indicate total numbers.